Bhavishya Saluja | Head of Product Strategy
Ultragenic
Bhavishya Saluja is Head of Product Strategy at Ultragenic, where he leads the vision, strategy, and evolution of next-generation pharmacovigilance platforms spanning AI-enabled case intake, signal detection, literature surveillance, and safety intelligence. With over 13 years of experience in pharmacovigilance technology and product leadership, he focuses on helping life sciences organisations modernise safety operations through scalable, compliant, and data-driven innovation. His current focus is on shaping hybrid workforce models where AI agents and pharmacovigilance professionals work together to improve the speed, quality, and consistency of safety decision-making while maintaining human oversight and accountability.
Appearances:
Day 1: 14th October @ 15:30
Signal Detection for a Hybrid Workforce - Humans and AI Agents Working Together
As signal volumes grow and safety teams face increasing resource pressures, the future of signal detection is not human versus AI, but human and AI working together. This session explores how AI agents can continuously monitor data, identify emerging patterns, prioritise potential risks, and prepare evidence for review, while safety professionals provide oversight, context, and scientific judgement. Attendees will learn how leading organisations are building hybrid operating models that balance automation, transparency, compliance, and accountability to accelerate signal detection, improve decision-making, and ultimately strengthen patient safety outcomes.
Get Involved At patient Safety Congress Americas
CONNECT WITH US
Marketing & Press
Karolina Bzikot
karolina.bzikot@terrapinn.com
Created by
Terrapinn is proud to be a member of isla.
Working together to build sustainable events